ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 教員研究業績
  2. 衛生学研究室
  3. 原著論文

Utility of murine dendritic cell line DC2.4 for in vitro assay of skin-sensitization potential

https://gifu-pu.repo.nii.ac.jp/records/13123
https://gifu-pu.repo.nii.ac.jp/records/13123
4a23c5fc-ff8a-4950-81ad-0424cbb7e9da
Item type 研究室原著論文(1)
公開日 2018-06-13
タイトル
タイトル Utility of murine dendritic cell line DC2.4 for in vitro assay of skin-sensitization potential
言語 en
言語
言語 jpn
キーワード
言語 en
主題Scheme Other
主題 Dendritic cell
キーワード
言語 en
主題Scheme Other
主題 Allergic contact dermatitis
キーワード
言語 en
主題Scheme Other
主題 Local lymph node assay (LLNA)
キーワード
言語 en
主題Scheme Other
主題 Human cell line activation test (h-CLAT)
キーワード
言語 en
主題Scheme Other
主題 CD86
キーワード
言語 en
主題Scheme Other
主題 CD54
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
アクセス権
アクセス権 metadata only access
アクセス権URI http://purl.org/coar/access_right/c_14cb
抄録
値 Animal tests, such as the local lymph node assay (LLNA), are the gold standard for assaying skin-sensitizing potential. However, because of concerns about animal welfare, extensive research has been conducted on the use of various cell lines, such as human leukemia cells, for in vitro assays of skin-sensitizing potential, but such assays have not replaced animal tests as stand-alone assays. Because Langerhans cells—a type of dendritic cell—are the main antigen-presenting cells in the epidermis and because they play a central role in the induction of allergic skin disorders, these cells may be useful for skin-sensitizing-potential assays. Here, we investigated the utility of the murine dendritic cell line DC2.4 for in vitro assay of the skin-sensitization potential of 2,4-dinitrochlorobenzene (DNCB), 2-mercaptobenzothiazole (MBT), and α-hexyl cinnamaldehyde (HCA), which are categorized as extremely, moderately, and weakly sensitizing, respectively, on the basis of LLNA results. DC2.4 cell viability decreased dose-dependently with increasing concentration upon treatment with each of the compounds for 24 hr; the DNCB, MBT, and HCA concentrations that resulted in 75% cell viability were 6.07, 120.14, and 118.70 μg/mL, respectively. At nontoxic concentrations (concentrations less than the 75% cell viability concentrations), these compounds dose-dependently upregulated the expression of both CD86 and CD54 on the surface of DC2.4 cells. Their potency decreased in the order DNCB > MBT > HCA, which agrees with the order indicated by the LLNA. These results suggest that DC2.4 cells may be a viable replacement for human leukemia cells in in vitro assays of skin-sensitization potential.
書誌情報 en : Fundamental Toxicological Sciences

巻 4, 号 3, p. 121-126, 発行日 2017-06-09
戻る
0
views
See details
Views

Versions

Ver.1 2023-06-19 08:58:58.373905
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3